GOUBIER; Anne
Patent Applications and Registrations
Patent applications and USPTO patent grants for GOUBIER; Anne.The latest application filed is for "cd38 antibody".
- GOUBIER; Anne - Stevenage Hertfordshire GB
- Goubier; Anne - Stevenage GB
- Goubier; Anne - Hertfordshire GB
- GOUBIER; Anne - Welwyn Garden City GB
- Goubier; Anne - Sauveterre de Bearn N/A FR
| Patent | Date |
|---|---|
| Cd38 Antibody App 20220135697 - GOUBIER; Anne ; et al. | 2022-05-05 |
| CD38 antibody Grant 11,236,173 - Goubier , et al. February 1, 2 | 2022-02-01 |
| Cd38 Modulating Antibody Agents App 20210277138 - Merchiers; Pascal ; et al. | 2021-09-09 |
| Anti-cd25 Antibody Agents App 20210054084 - Goubier; Anne ; et al. | 2021-02-25 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210047420 - Goubier; Anne ; et al. | 2021-02-18 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210040221 - Goubier; Anne ; et al. | 2021-02-11 |
| Anti-cd25 Antibody Agents App 20210009699 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210009704 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210009702 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 For Tumour Specific Cell Depletion App 20210009703 - Goubier; Anne ; et al. | 2021-01-14 |
| Anti-cd25 Antibody Agents App 20200407454 - Goubier; Anne ; et al. | 2020-12-31 |
| Cd38 Modulating Antibody App 20200362049 - GOUBIER; Anne ; et al. | 2020-11-19 |
| Cd38 Antibody App 20200362050 - GOUBIER; Anne ; et al. | 2020-11-19 |
| Compounds And Methods For Tumour-specific Cell Depletion App 20200283535 - MERCHIERS; Pascal ; et al. | 2020-09-10 |
| Anti-CD25 antibody agents Grant 10,752,691 - Goubier , et al. A | 2020-08-25 |
| Anti-CD25 antibody agents Grant 10,745,485 - Goubier , et al. A | 2020-08-18 |
| Anti-CD25 antibody agents Grant 10,738,125 - Goubier , et al. A | 2020-08-11 |
| Cd38 Modulating Antibody App 20200190209 - Merchiers; Pascal ; et al. | 2020-06-18 |
| Fc-optimized Anti-cd25 For Tumor Specific Cell Depletion App 20200010554 - Goubier; Anne ; et al. | 2020-01-09 |
| Anti-cd25 Antibody Agents App 20190322752 - Goubier; Anne ; et al. | 2019-10-24 |
| Anti-cd25 Antibody Agents App 20190300613 - GOUBIER; ANNE ; et al. | 2019-10-03 |
| Anti-cd25 Antibody Agents App 20190284287 - Goubier; Anne ; et al. | 2019-09-19 |
| CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses Grant 9,902,947 - Esquerre , et al. February 27, 2 | 2018-02-27 |
| HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders Grant 9,827,302 - Misseri , et al. November 28, 2 | 2017-11-28 |
| Hpv/cyaa-based Chimeric Proteins And Their Uses In The Induction Of Immune Responses Against Hpv Infection And Hpv-induced Disorders App 20150250867 - Misseri; Yolande ; et al. | 2015-09-10 |
| Cyaa-carried Polypeptide(s) And Use To Induce Both Therapeutic And Prophylactic Immune Responses App 20140037670 - EsquerrE; Michael ; et al. | 2014-02-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 